Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O9LR
|
|||
Former ID |
DNC012646
|
|||
Drug Name |
4-[3-(4-Butyl-phenoxy)-propyl]-1H-imidazole
|
|||
Synonyms |
CHEMBL419654; 4-[3-(4-Butyl-phenoxy)-propyl]-1H-imidazole; SCHEMBL7991257; NKIFZJYIQSBUEI-UHFFFAOYSA-N; BDBM50093221; [3-(4-Imidazolyl)propyl](4-butylphenyl) ether; 4-Butylphenyl 3-(1H-imidazol-4-yl)propyl ether
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H22N2O
|
|||
Canonical SMILES |
CCCCC1=CC=C(C=C1)OCCCC2=CN=CN2
|
|||
InChI |
1S/C16H22N2O/c1-2-3-5-14-7-9-16(10-8-14)19-11-4-6-15-12-17-13-18-15/h7-10,12-13H,2-6,11H2,1H3,(H,17,18)
|
|||
InChIKey |
NKIFZJYIQSBUEI-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists. Bioorg Med Chem Lett. 2000 Oct 16;10(20):2379-82. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.